Blocking lactate production in tumor cells or deleting HIF-1α in MDSCs reverse anti-tumor T-cell responses and effectively inhibite tumor progression after radiotherapy for pancreatic cancer patients (136). The gene discussed is HIF1A; the disease is neoplasm.